Revision total hip replacement has a failure rate of up to 25%. Part of the reason for this high failure is the lack of bone stock. In this study, we investigated whether mesenchymal stromal cells (MSCs) or osteoprogenitors (OPs) contribute to bone formation in impacted allograft or an allograft and hydroxyapatite (HA) combination. Eight samples were inserted in the paraspinal muscles of six sheep, which were allograft or an HA=allograft mix, seeded with autologous MSCs, autologous OPs, or no cells (control), and impacted with a clinically relevant force at 3 kN preimplantation. Other groups were HA blocks seeded with or without MSCs. Samples were retrieved at 12 weeks. MSCs incorporated into allograft, HA=allograft, and HA blocks displayed higher mean values of new bone formation compared with the controls, but there was no statistical difference between allograft groups. However, in HA=allograft groups, significantly more new bone was found with MSCs than without cells ( p ¼ 0.046) or with OPs ( p ¼ 0.028). In the HA blocks, more new bone was found in the MSC group than in the HA block without cells ( p ¼ 0.028). In conclusion, MSCs used with combinations of allograft and HA enhance new bone formation in an ovine ectopic site after being subjected to realistic forces that are used during impaction grafting.
Introduction

R
evision total hip replacements (THR) due to aseptic loosening, caused by wear particle-induced osteolysis, account for 9% of total hip operations, with over 6000 per year in the United Kingdom alone. 1 Osteolysis can be local, but more often results in gross bone remodeling and damage. The reduction of bone stock available for subsequent implant fixation is responsible for worse results in revision surgery compared with the primary THR. 2 The main aims of revision procedures are to achieve immediate fixation and long-term stability, combined with the restoration and maintenance of bone stock. Despite the intrinsic capacity of bone to regenerate and repair using techniques that involve impaction of autograft or allograft bone, 3 major complications of bone fracture and massive early subsidence of the femoral stem have deterred surgeons from using this technique. 4 Autograft is osseoinductive, meaning that the material has the ability to drive and differentiate mesenchymal stem cells along the osteogenic lineage. 5 Harvest of the autograft can result in donorsite pain and often there is not enough graft available for the reconstruction of the proximal femur. For this reason allograft bone is mainly used. However, at best allograft is osseoconductive, meaning that the graft can recruit and promote bone formation along the implant surface. 6 Additionally, concerns of bone allograft shortages, contamination, immunogenicity, and mechanical consistency, limit the wider application of this technique. 7 These limitations have prompted a search for alternative bone graft materials. Bone graft substitutes are usually based on calcium phosphate materials and are defined as being osseoconductive. This study examines the potential for mesenchymal stromal cells (MSCs) and osteoprogenitors (OPs) derived from MSCs to induce bone in impaction bone grafting using allograft and mixtures of allograft and hydroxyapatite (HA) . In this study we use an ovine model of ectopic bone formation where bone graft substitute materials and allograft are combined with autologous MSCs to determine the osseoinductive potential of these combinations. Importantly, in this model we have impacted the bone graft materials with MSCs before implantation and have used impact forces similar to those used during revision hip surgery 8 that does initially decrease the metabolic activity of these stromal cells, and this may effect bone formation. We hypothesize that by combining allograft and mixtures of allograft and bone graft substitute materials with autologous MSCs and autologous OPs in impaction grafts, we will be able to induce osseoinductivity of these materials in an ectopic site.
Materials and Methods
Allograft preparation
Ovine femurs and humeri were harvested at sacrifice and cleaned of soft tissue. The cortical bone was removed using a band saw and remaining cancellous bone cut into small pieces. These pieces of cancellous bone were morselized through a Lere Bone Mill (Depuy, Warsaw, IN), and washed in an ultrasonic bath with warm water (temperature at 558C) for 15 min to remove cell debris and blood. Then, three consecutive washes of 15 min each with warm water were followed by a 10 min wash with 70% ethanol to denature cellular proteins and to kill viruses and bacteria.
Once the graft had been washed, excess liquid was removed using paper towels. The graft was size sorted using a sieve shaker. About 2-5-mm-diameter allograft granules were measured into 3.5 g aliquots. These were individually double packaged and double heat sealed and stored at minus 208C until sterilization. The frozen graft was sterilized using gamma irradiation at 25KGrays (Isotron, Reading, United Kingdom). The graft was stored at À208C before surgery.
Hydroxyapatite
HA granules (Apapore 60Ô), 2-5 mm diameter for impaction, and blocks 60=400 were supplied by Apatech (Hertfordshire, United Kingdom). The 50:50 mixture of granules and graft was frozen in 3.5 g quantities and gamma irradiated. Similarly, HA granules and HA blocks were sterilized by gamma irradiation.
MSC isolation
Under sterile conditions, 4 mL of bone marrow was aspirated from the ovine iliac crest into 5 mL syringes loaded with 1000 international units of heparin. The MSCs were separated using a Ficoll-Paque Ò (Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom) density gradient. The straw-colored buffy layer was recovered and resuspended in Dulbecco's modified Eagle's medium (DMEM). This was recentrifuged to produce a pellet of cells at the bottom of the flask. The supernatant, remaining Ficoll gradient, and medium were removed, and the pellet of cells was resuspended again in DMEM. The cell suspension was plated into T25 flasks and maintained at 378C in a fully humidified atmosphere containing 95% air and 5% carbon dioxide. Cells were allowed to adhere to the flasks (2-3 days) and the medium then changed. When the cells had become confluent within the cell culture flasks, they were trypsinized and then resuspended (passaging). Cells between passages 2 and 3 were used in this study.
Osteogenic differentiation
OPs were differentiated from MSCs. After passage 2, MSCs were cultured in osteogenic medium for 14 days. The osteogenic medium was made up of DMEM (DMEM; D-6429; Sigma, Dorset, United Kingdom), with 10% fetal calf serum (First Link, West Midlands, United Kingdom) and penicillin=streptomycin (1000 IU=mL; 100 mg=mL) (Gibco, Paisley, United Kingdom) supplemented with 10 mM bglycerophosphate (D1756; Sigma), 50 mg=mL ascorbic acid (A4544; Sigma), and 1Â10
À8 M dexamethasone (D-2915; Sigma). The medium was changed every 3 days.
Alkaline phosphatase
At the end of day 1 and at days 7, 14, 21, and 28, the amount of alkaline phosphatase produced was analyzed. The medium in the wells was discarded and replaced with 1 mL of distilled water. The plate was placed in the À708C freezer to lyse the cells and then thawed in a 378C incubator. This was then repeated twice. The samples were thawed at 48C overnight to allow regeneration of enzyme activity. Samples were assayed by an automated process in the COBAS BIO centrifugal analyzer (Roche, Hertfordsire, United Kingdom). The reagent p-nitrophenol phosphate (Randox Laboratories, Antrim, United Kingdom) was added to the samples whereby alkaline phosphatase (ALP) cleaved the phosphate group to give p-nitrophenol, which is yellow at alkaline pH and is monitored in the COBAS BIO (Roche) at 405 nm. This gave a measurement of the activity of the enzyme. Enzyme activity was expressed as U=L=1Â10 6 cells, where U is the amount of the enzyme that transforms 1 mmol of substrate per minute. The concentration is expressed as units per liter.
Osteocalcin
After lysing cells in a freeze-thaw process, osteocalcin levels were analyzed using an ELISA assay (Metra-Biosystems, Dorking, United Kingdom). The optical density of the samples was measured at 405 nm using a Dynotech MR700 plate reader (Dynotech Laboratories, Kent, United Kingdom). The number of cells were counted using a hemocytometer and were used to normalize the amount of ALP and osteocalcin produced.
Perioperative seeding of the graft
On the day of surgery, autologous MSCs or OPs were trypsinized from the culture flasks and placed in 7 mL of DMEM for transport to the operating theatre. OPs were harvested after 14 days of differentiation, and agglomerations of OPs were mechanically disrupted using a Pasteur pipette to produce a single-cell suspension. The cells were counted using a hemocytometer. The cell suspension was centrifuged to produce a cell pellet. Autologous sheep blood was taken during surgery and centrifuged to produce a cell layer and plasma layer. The plasma layer was used to resuspend the MSCs at 10Â10 6 cells=mL of plasma. The plasma-cell mix was seeded onto the scaffold and allowed to form a clot before implantation. The concentration of cells in plasma was 10Â10 6 cells=mL. Plasma was used at 0.9 mL=g of scaffold to achieve full coverage of the graft with plasma. The blocks were seeded with 9Â10
6 MSCs=g of HA.
Surgery
All procedures were carried out in accordance with the Animals (Scientific Procedures) Act 1986. Six adult sheep were used. With the animal anesthetized and under aseptic conditions, each sample was placed and fully covered within the paraspinal muscle belly adjacent to the lumbar vertebrae,
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with four implants located in an anterior-posterior line on one side of the spine and four others on the other side of the spine. Each sheep received 8 scaffolds (8 study groups) in the paraspinal muscles, which were (1) 
Impaction
Under aseptic conditions the clotted sample was transferred into a titanium mesh sleeve positioned within a Delrin tube and then placed in the impactor. Intraoperative measurement of femoral impaction forces ranges from 3 to 9 kN, with the majority of impactions between 3 and 6 kN. 9 Compaction of the graft was accomplished after 20 compactions, and further impaction at this load did not result in any greater compaction. The dimensions of the grafts were 15 mm in diameter and 12 mm in length in the allograft group and 15 mm in length in the HA=allograft group after impaction. In vitro MSCs have been shown to survive impaction forces of up to 6 kN, with full recovery within 6 days. 8 For this study, the impactor was calibrated to 2.5 cm weight drop (3 kN) and 20 impactions were performed (Fig. 1) . The impacted sample surrounded by the mesh was removed and closed at both ends with an absorbable Vicryl suture.
Implant processing
All implants were retrieved, with the surrounding muscle after 12 weeks. Samples were fixed in buffered formal saline dehydrated in ascending concentrations of industrial methylated spirits and defatted with chloroform before embedding in LR white resin (London Resin Company, Berkshire, United Kingdom). The samples were cut longitudinal using an EXAKT diamond band saw (EXAKT Vertriebs, Nordestedt, Germany) before preparing a 60-mmthick section, by grinding and polishing. All samples were stained with Toluidine Blue for 15 min, washed with water, and then stained using Paragon for 20 min. Slides were examined using a light microscope. Digital photos were taken and analyzed using Image Tool 3.0 software (UTHSCSA, San Antonio, TX). The area of new bone, remaining allograft, and remaining HA was quantified. Percentage new bone formation was expressed as the amount of new bone within the mesh. New bone in contact with scaffold was quantified by an intersecting line technique. This was determined as a percentage by defining whether bone or fibrous tissue was in contact with the edge of the scaffold where it intersected with lines on an overlayed grid pattern of 500 mm. 10 
Statistical analysis
Data analysis was carried out using a Friedman two-way analysis of variance on nonparametric data to examine any differences between scaffold groups. If a significant difference was found, a post hoc pair-wise Wilcoxon test was used to examine any differences between two groups. The statistical software SPSS (SPSS v10.1; SPSS, Chicago, IL) was used for the analysis. In the Results section data are expressed as mean AE standard error of the mean (SE) values. The bars on the histograms are standard error. All data are taken from measurements of implants in six animals. Therefore, for our analysis n ¼ 6.
Results
MSC differentiation
At 7 and 14 days the ALP activity was always higher in the cells grown in the osteogenic medium compared with the control MSCs treated with the standard medium. The largest increase in this enzyme activity was at day 7 (Fig. 2a) . Osteocalcin production increased from day 7 and continued to increase up to day 28 (Fig. 2b) . Therefore, on balance, the OPs used in vivo were defined as those treated with the osteogenically supplemented medium for 14 days. The OP cells used in this study are therefore more differentiated at 14 days than cells with peak ALP activity at 7 days; however, at this time they do not produce mineral and are therefore not completely differentiated.
Histology
In this model, bone forms directly without endochondral ossification. New bone on the allograft forms in coastal areas In some cases there was evidence of new bone forming without attachment to a scaffold. In the grafts containing combinations of HA and allograft, new bone predominantly formed in pores of the HA and occasionally bridged granules (Figs. 3 and 5) . The remaining allograft was associated with new bone that formed on the surface of the graft bone. There was very little new bone adjacent to the surface of the granules of HA, but bone was found within small pores measuring less than 50 mm. Within the HA pores bone formed in a centrifugal manner with bone growth associated more with the wall of the pore (Fig. 3) .
New bone formation
Scaffolds with MSCs incorporated into allograft, 50:50 HA=allograft, and block groups displayed higher mean values of new bone area at 4.98% AE 2.28 SE, 5.15% AE 1.98 SE, and 7.09% AE 3.31 SE, respectively, compared with the controls at 2.24% AE 1.03 SE, 1.96% AE 0.79 SE, and 1.96% AE 0.98 SE, respectively. The osteoblast groups produced less new bone with 2.19% AE 1.17 SE in the allograft group and 0.82 AE 0.26 SE in the 50:50 HA=allograft group (Fig. 6 ). In the allograft group there was a 179% increase in new bone formation with the addition of MSCs compared with the control. However, Wilcoxon-signed rank analysis showed no significant difference between treatments in the allograft group even though there was a greater amount of bone in the MSC-treated samples ( Table 1) . The allograft at 12 weeks had resorbed such that at this time allograft represented 1.08%, 2.82%, and 1.55% of the area in the control, MSC, and OP groups, respectively, whereas at time zero allograft accounted for 39%. The area of HA at time zero was 49%. The HA at 12 weeks had resorbed to a much lesser extent representing 38.63%, 41.57%, and 40.36% of the area in the control, MSC, and OP groups, respectively.
In the combined allograft and HA groups, Friedman analysis and Wilcoxon-signed rank post hoc tests (Table 1) revealed significantly more new bone in the 50:50 HA= allograft MSC sample compared with the 50:50 HA=allograft control ( p ¼ 0.046) or 50:50 HA=allograft OP samples ( p ¼ 0.028). There was also a significantly greater amount of new bone in the block MSC samples, which had the highest mean new bone (7.09% AE 3.31 SE) compared with the block without cells ( p ¼ 0.028).
MSCs produce more new bone in contact with the scaffold compared with the other groups ( Fig. 7) with means of 39.52% AE 17.77 SE, 8.53% AE 3.16 SE, and 14.15% AE 6.70 SE in allograft, 50:50 HA=allograft, and HA Block groups, respectively, compared with the controls at 29.97% AE 14.80 SE, 2.66% AE 0.81 SE, and 8.22% AE 2.43 SE, respectively. The OP groups produced the least amount of new bone in contact with the scaffold surface within each group. However, there was no significant difference between treatments in any scaffold group in terms of new bone in contact with the scaffold surface.
The absolute new bone formation within the total area for the MSC-seeded allograft, 50:50 HA=allograft, and block groups was 4.68% AE 1.91 SE, 3.00% AE 1.23 SE, and 3.18% AE 1.30 SE, respectively, and 2.21% AE 0.90 SE, 1.09% AE 0.45 SE, and 1.00% AE 0.41 SE in the respective control groups. The mean percentage of absolute new bone in the total area in the OP group was 2.10% AE 0.86 SE on allograft and 0.48% AE 0.20 SE on HA=allograft.
Discussion
Impaction allograft is used to reconstitute the bone stock around failed joint replacement prostheses; however, allograft is used because often there is not enough autograft 
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available and there is donor-site morbidity. Bone substitute materials are also being used to avoid disease transmission. Overall, autograft is considered to be preferable because it contains living cells that are thought to contribute to bone formation. 11 In this study we compared allograft and calcium phosphate materials augmented with MSCs and OPs to increase the osseoinduction of graft.
All groups showed a degree of bone formation. Control groups composed of allograft alone, HA=allograft, and HA blocks showed little difference. This indicates that allograft sterilized and treated by the methods used in this study has limited osseoinductivity. In all cases there is an increase in new bone formation when MSCs are used. MSCs in the block HA, as well as in impacted allograft and HA=allograft, induced greater bone formation. Our study has used combinations of allograft and HA together with MSCs at a clinically relevant volume. The average volume of osteolytic defects measured by Looney et al. using computerized tomography around revision THR averaged 30.0 mm. 3, 12 Animal models have been used to demonstrate the effectiveness of MSCs in bone regeneration. Petite et al. and Kon et al. have used expanded autologous MSCs to increase new bone formation in critical-sized bone defects in sheep models. 13, 14 Although different anatomically and biomechanically, the sheep model provides a similar weight and size to humans. It also has a bone healing rate similar to humans, and the bone mineral composition does not differ appreciably. 15 Using the techniques described in this current paper, we have previously differentiated sheep MSCs into adipocytes, chondrocytes, and osteoblasts 16 and demonstrated an increase in bony contact and in-growth to massive endoprostheses when the implant was sprayed with autologous MSCs in a sheep model. 17 The majority of tissue-engineered scaffolds used for bone are calcium phosphate ceramics. In 1996, Magan and Ripamonti reported osseoinduction within the concavities of HA discs implanted into the rectus abdominis of adult baboons. 18 However, they looked at monolithic discs, not porous scaffolds. Our study confirms the osseoinductive nature of HA when implanted in an ectopic site and supports Ripamonti's work, indicating that surface topography may influence the osseoinductive nature of HA. Our study used HA with an average pore size of 400 mm and a porosity of 60%. Other reported studies have used different calcium phosphate bone substitutes. Using a mouse ectopic model, Arinzeh et al. 19 investigated various HA=B-tricalcium phosphate (TCP) combination scaffolds. TCP is osseoinductive but rapidly degrades and resorbs. 20 The combination of both HA and TCP has been shown to induce bone formation in large, long bone defects. Livingston et al. demonstrated that a 20:80%, HA:TCP scaffold stimulated the greatest new bone formation after 6 weeks in a canine femoral defect model. 21 Therefore, more new bone formation may have been seen with the use of different scaffold compositions. TCP would be subject to resorption and release of particles that may be inflammatory, and the reason we chose to use HA in our model was to avoid complications associated with degradation of graft and release of particles. The use of HA may confer more stability to the graft as it does not resorb as easily as allograft and therefore provides a scaffold for osseoinduction and more long-term mechanical support for an implant. Studies have predominantly used ceramic blocks as scaffolds, and not granules. 13, 14, 22 For THR impaction grafting uses granules rather than blocks. This is more clinically relevant because the graft needs to be shaped into the defects that are present after the hip is removed during revision surgery. This is not possible with a blocks of HA. Our study used HA granules ranging from 2 to 5 mm in diameter. Previously published data have used large single blocks of HA. 13 In THR, excessive micro motion between the implant-bone interface leads to bone resorption. 23 Lacroix et al. stated high shear strain stimulates MSCs to differentiate and form fibrous tissue, whereas lower levels are needed to produce cartilage and bone. 24 The use of granules as a scaffold in an ectopic site may produce high levels of inter-granular strain, and therefore may inhibit new bone formation. Impaction bone grafting uses large forces. These forces were quantified, and an impaction device was constructed to reproduce these forces. 8, 25 Using this impactor, sheep MSCs were shown to survive the forces of impaction in vitro. 8 Previously, studies using animal models have shown that MSCs are osseoinductive. In 2000, Kon et al. described a pilot study using two sheep. They loaded HA blocks with autologous culture-expanded ovine MSCs to fill critical-sized tibial defects. More new bone was found in the tissue-engineered constructs, and they were also stiffer. 13 In an ectopic study in eight goats, scaffolds were seeded 6 days or 14 h before surgery with MSCs. There was more new bone formation (9-13% vs. 3-5%) in the 6-day group. There was also no reduced effect of using autologous plasma as a seeding medium. 26 In our study, cells were resuspended in autologous plasma and seeded onto the scaffold at the time of operation; therefore, production of an extracellular matrix (ECM) before implantation by the MSCs was not possible. Scaffolds cultured with MSCs for 6 days and implanted in a rat model have also demonstrated more new bone than noncultured constructs. 27 During culture it was suggested that the MSCs produce an ECM that aided new bone formation. On the contrary, Kruyt et al. demonstrated that cells seeded at the time of operation produced equivalent amounts of new bone as cultured cells. In their study, they concluded that the presence of viable MSCs on a scaffold was more important than the presence of an ECM. 28 Although the percentage of bone formed in our study was low, it is in line with other published data looking at stem cells on bone graft materials in ectopic sites. 26, [28] [29] [30] Previous studies have used a similar number of cells as our study. Arinzeh et al. 19 28, 29 In this study allograft groups were 5 mL (5 cm   3 ) and HA= allograft mixtures were 6 mL (6 cm ). This equates to 6Â10 6 MSCs=cm 3 in the allograft groups and 5Â10 6 MSCs=cm 3 in the HA=allograft mix.
In our study there was no increase in new bone with the seeding of OPs on impacted allograft or impacted HA= allograft mix. Osteoblastic differentiation was achieved by the addition of osteogenic supplements (dexamethasone, bglycerophosphate, and ascorbic acid) to the culture medium. Previous studies have shown the differentiation of both rat and human mesenchymal stem cells with such supplementation. 32, 33 Osteoblastic differentiation was shown with increased alkaline phosphatase activity and the production of osteocalcin and the formation of a mineralized matrix. The results from the ALP assay followed a characteristic trend observed in studies published in the literature on the differentiation of stem cells into osteoblasts using bglycerophosphate, ascorbic acid, and dexamethasone. 34 In our study ALP activity peaked on day 7, and was followed by an immediate decline in activity. The reduction in ALP activity correlates with an up-regulation of osteocalcin expression (Fig. 2b) . ALP is an enzyme that prompts phosphate ions to accumulate on collagen fibrils 35 and is expressed in osteoblasts. ALP peaks in expression and then declines 36 because the function of ALP is to encourage mineral deposition, which requires collagen to be present first. Osteocalcin is a structural protein of the ECM of bone that is produced by osteoblasts. 37, 38 The ALP and osteocalcin data indicated that the cells were differentiated along the osteogenic lineage, and we termed these cells OPs. The techniques established that on and after day 14, the cultures contained a population of functionally active secretory osteoblasts. In a previous study, we have shown that these cells do produce bone mineral at 28 days. 10 A study by Castano-Isquierdo, investigating the influence of the preculture period of MSCs in the osteogenic medium on in vivo bone-forming potential, showed that preculturing of MSCs in osteogenic media for 4 days yielded more bone in cranial implants on titanium mesh fibers after 1 month than 16 days of preculturing in osteogenic media. 39 They found that the osteoblasts produced significantly less bone than MSCs. This evidence suggests that a shorter time period of culture in the osteogenic medium may have increased the osteoinductivity of the cells in this study. This may be because the long exposure of the bone marrow stromal cells (BMSCs) to the osteogenic medium may have 
allowed their differentiation but restricted their ability to increase their number after implantation. 39 Wherever bone is formed it is usually in contact with scaffold surface, and bone formed by intramembranous ossification and endochondral ossification is never seen. This is in contrast to osseoinduction by bone morphogenic proteins that usually proceeds by a endochondral route. 39 This suggests that the bone graft material is responsible for osseoinduction that is accomplished by a different mechanism from that seen with bone morphogenic proteins.
The use of MSCs is encouraging in producing increased new bone in impaction grafting. Culturing the MSCs onto the individual scaffolds for 6 days 26 before impaction and the use of HA 70=800 (70% porosity and 800 mm average pore size) 26 may induce further new bone formation. Further work should investigate the contribution of MSCs to new bone formation by labeling MSCs with GFP genes or other markers such as Lac Z. This ectopic study demonstrates increased new bone formation in impacted allograft and impacted HA=allograft mixture seeded with autologous MSCs when compared with respective controls. The amount of new bone is small and further studies are needed to evaluate whether this would have a significant clinical effect in the longer term.
